- Home
- PAYS vs ALEC Comparison
PAYS vs ALEC Comparison
Compare PAYS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYS
- ALEC
- Stock Information
- Founded
- PAYS 2001
- ALEC 2013
- Country
- PAYS United States
- ALEC United States
- Employees
- PAYS N/A
- ALEC N/A
- Industry
- PAYS Business Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAYS Consumer Discretionary
- ALEC Health Care
- Exchange
- PAYS Nasdaq
- ALEC Nasdaq
- Market Cap
- PAYS 125.2M
- ALEC 124.0M
- IPO Year
- PAYS 1998
- ALEC 2019
- Fundamental
- Price
- PAYS $4.45
- ALEC $1.33
- Analyst Decision
- PAYS Strong Buy
- ALEC Buy
- Analyst Count
- PAYS 4
- ALEC 7
- Target Price
- PAYS $6.56
- ALEC $4.70
- AVG Volume (30 Days)
- PAYS 403.0K
- ALEC 1.2M
- Earning Date
- PAYS 05-08-2025
- ALEC 05-08-2025
- Dividend Yield
- PAYS N/A
- ALEC N/A
- EPS Growth
- PAYS N/A
- ALEC N/A
- EPS
- PAYS 0.11
- ALEC N/A
- Revenue
- PAYS $63,792,627.00
- ALEC $88,339,000.00
- Revenue This Year
- PAYS $25.98
- ALEC N/A
- Revenue Next Year
- PAYS $14.22
- ALEC $392.45
- P/E Ratio
- PAYS $40.62
- ALEC N/A
- Revenue Growth
- PAYS 26.77
- ALEC N/A
- 52 Week Low
- PAYS $1.80
- ALEC $0.87
- 52 Week High
- PAYS $5.59
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- PAYS 79.28
- ALEC 55.51
- Support Level
- PAYS $3.31
- ALEC $1.01
- Resistance Level
- PAYS $4.58
- ALEC $1.46
- Average True Range (ATR)
- PAYS 0.30
- ALEC 0.12
- MACD
- PAYS 0.10
- ALEC 0.02
- Stochastic Oscillator
- PAYS 92.86
- ALEC 71.11
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.